🇺🇸 FDA
Patent

US 7432331

Hydrolytically stable maleimide-terminated polymers

granted A61KA61K47/60

Quick answer

US patent 7432331 (Hydrolytically stable maleimide-terminated polymers) held by Nektar Therapeutics AL, Corporation expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics AL, Corporation
Grant date
Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K47/60